Newsweek reached out to Novo Nordisk and Eli Lilly, manufacturers of several leading GLP-1 medications, for comment
It does three things that drive weight loss and also explain virtually every side effect on this list: Slows gastric emptying food stays in the stomach longer nausea, reflux, bloating, Ozempic burps Suppresses appetite via the brain reduced food intake headaches, fatigue, low energy from low calories Reduces gut motility slower transit constipation
Each vial contains 50mg of 5-Amino-1MQ and is supplied exclusively for professional research purposes
Regular monitoring and adjustments based on individual responses can help ensure effective and safe treatment
Given the high risk of sarcopenic obesity and metabolic adaptations after significant weight loss, future clinical trials are needed to assess optimal dietary patterns, protein dosing and timing, protein supplementation, and resistance training interventions to better promote muscle health outcomes during weight loss
[6] Federal Trade Commission